dehydroepiandrosterone sulfate has been researched along with Cancer of Gastrointestinal Tract in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abe, T; Adachi, H; Asano, N; Date, F; Fujiwara, K; Iinuma, K; Ito, S; Kakyo, M; Kondo, TN; Kondo, Y; Matsuno, S; Nagura, H; Nakagomi, R; Nishio, T; Nunoki, K; Ohtani, H; Okabe, M; Ono, K; Onogawa, T; Sato, E; Seki, M; Shiiba, K; Shimosegawa, T; Sugita, J; Suzuki, M; Suzuki, T; Tanemoto, M; Tokui, T; Unno, M | 1 |
1 other study(ies) available for dehydroepiandrosterone sulfate and Cancer of Gastrointestinal Tract
| Article | Year |
|---|---|
LST-2, a human liver-specific organic anion transporter, determines methotrexate sensitivity in gastrointestinal cancers.
Topics: Amino Acid Sequence; Animals; Anion Transport Proteins; Antimetabolites, Antineoplastic; Carrier Proteins; Gastrointestinal Neoplasms; Humans; Immunohistochemistry; Liver; Methotrexate; Molecular Sequence Data; Xenopus laevis | 2001 |